![Robert Goodenow](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert Goodenow
Keine laufenden Positionen mehr
Profil
Robert S.
Goodenow is currently the Chief Executive Officer at Alanis Therapeutics, Inc. He previously worked as a Principal at Baxter International, Inc., Head-Oncology Business Development at Aventis, Inc., Secretary & Chief Business Officer at Syndax Pharmaceuticals, Inc., and Chief Business Officer at HUYA Bioscience International LLC.
From 2002 to 2007, he served as the Vice President-Corporate Development at Inovio Pharmaceuticals, Inc. Dr. Goodenow holds a doctorate degree from Stanford University and an undergraduate degree from the University of California, Berkeley.
Aktive Positionen von Robert Goodenow
| Unternehmen | Position | Beginn |
|---|
Ehemalige bekannte Positionen von Robert Goodenow
| Unternehmen | Position | Ende |
|---|---|---|
| INOVIO PHARMACEUTICALS, INC. | Corporate Officer/Principal | 16.03.2007 |
Huyabio International LLC
 Huyabio International LLC Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Präsident | - |
| BAXTER INTERNATIONAL INC. | Corporate Officer/Principal | - |
Aventis, Inc.
 Aventis, Inc. MiscellaneousMiscellaneous Functions as an investment holding company | Corporate Officer/Principal | - |
| SYNDAX PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Ausbildung von Robert Goodenow
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
10
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Baxter International, Inc.
 Baxter International, Inc. Medical SpecialtiesHealth Technology Produces and supplies medical products, healthcare systems, therapies and pharmaceuticals & provide kidney care services | Health Technology |
Aventis, Inc.
Aventis, Inc. MiscellaneousMiscellaneous Functions as an investment holding company | Miscellaneous |
Syndax Pharmaceuticals, Inc.
 Syndax Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Huyabio International LLC
Huyabio International LLC Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inovio Pharmaceuticals, Inc.
 Inovio Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops synthetic vaccines and immune therapies for cancers and infectious diseases | Health Technology |
Wählen Sie MarketScreener 
